Arthritis Rheumatoid clinical trials

Explore recruiting arthritis rheumatoid clinical trials.

Recruiting arthritis rheumatoid studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Arthritis Rheumatoid trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2a multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Burfiralimab (hzVSF-v13) added to disease-modifying antirheumatic drugs in patient with moderate to severe Rheumatoid Arthritis

Spain, Austria, Czechia, Poland, Netherlands, Hungary

Therapeutic exploratory (Phase II) EU CTIS Study details

Design and evaluation of an individualized biodrug tapering strategy based on biodrug dosage: the MONITORA study_STEP1

France

Therapeutic use (Phase IV) EU CTIS Study details

Non-inferiority study of TOCILIZUMAB in dose-banding versus dose-weight in rheumatoid arthritis with low activity or clinical remission

France

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pimozide after Multiple Dose Administration in Subjects with Rheumatoid Arthritis

Bulgaria

Human Pharmacology (Phase I)- Other EU CTIS Study details

An international, multicentre, interventional, randomised assessor-blinded trial to MAXimise the METHotrexate therapy potential in patients with active rheumatoid arthritis (MethMax trial)

Norway, Netherlands, Austria, Sweden, Romania, Italy

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Rheumatoid Arthritis

Poland, Spain, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Arthritis Rheumatoid trials by city

Arthritis Rheumatoid in Toronto Arthritis Rheumatoid in Vancouver Arthritis Rheumatoid in Montreal Arthritis Rheumatoid in Calgary Arthritis Rheumatoid in Edmonton Arthritis Rheumatoid in Ottawa Arthritis Rheumatoid in Winnipeg Arthritis Rheumatoid in Quebec City Arthritis Rheumatoid in Hamilton Arthritis Rheumatoid in Kitchener Arthritis Rheumatoid in London Arthritis Rheumatoid in Halifax Arthritis Rheumatoid in New York Arthritis Rheumatoid in Los Angeles Arthritis Rheumatoid in Chicago Arthritis Rheumatoid in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease